patient;Attention;Age at Diagnosis;BMI at Dg;Histology;Histology re_evaluated in DECICER;Histology re_evaluated notes;Stage_FIGO2014;Treatment strategy;Residual tumor PDS;Residual tumor IDS;Oper2_IDS cancelled;Oper2_laparoscopic evaluation;Oper2_explorative laparotomy;Oper2_debulking surgery;Oper1_Omental disease largest nodule_NEW;Oper2_Omental disease largest nodule_NEW;Primary chemotherapy cycles;NACT cycles;Post IDS chemotherapy cycles;Maintenance therary after 1st line;PARPi treatment;Patient card::Participation in clinical trials;Patient card::DrugTrial_name;Patient card::Drugtrial unblinded;CRS Omental;CRS Omental range;CRS3 residual tumor;RECIST 1.1 Response to NACT;Response to NACT radiologic evaluation made;Primary therapy outcome;Current phase of treatment;Progression Yes_No_ND;Survival;Cause of death;OS_KaplanM_allHGSC;PFS_KaplanM_allHGSC;PFI_KaplanM_allHGSC;Time from End of 1st line maintenance to 1st prog_Days TFI;Time from 1st prog to Death_Days Post progression survival;BRCA mutation any;BRCA mutation status in Clinical test;BRCA any in Decider;HR signature SBS3 pretreatment WGS;HR signature SBS3 per patient;HRD Clinical test result;Chronic illnesses at Dg;Chronic illnesses type;Previous cancer yes no;Previous cancer dg;Previous cancer_year;Excluded from PFI_calculations;Excluded from PFI calculations_ reason
patient1;dg from radiologic LN biopsy, no primary fresh samples PFI: based on CT, CA125 rises earlier with no radiologic prog;67;27,60945176;high grade serous;;;IVA;PDS;more than 10mm;more than 10mm;;No;;;over 5cm;over 5cm;5.0;3.0;;no;ND;No;FIRST, B96;;;;;;;Partial Response;;Yes;Dead;;802;691.0;936.0;;;;No BRCA mut;;HRP;;HRD negative;Yes;No;No;;;;
patient2;;58;23,50780533;high grade serous;;;IIIC;PDS;1 to 10mm;0;No;;No;Yes;Over 5cm;;6.0;3.0;;;ND;No;;;2;;;Progressive disease after NACT;;Complete Response;Follow-up ;Yes;Alive;death due to cancer;1108;4506.0;454.0;;;;No BRCA mut;No;;;;Yes;COPD, Astma, Reumatoid artritis, Hypertension, Cardiac arrhythmias;No;;;;
patient3;;65;21,2585034;high grade serous;;;IVB;PDS;;0;;;No;;over 5cm;;5.0;;;No;ND;Yes;;;3;;;;Yes;Partial Response;Primary chemotherapy;Yes;Alive;death due to cancer;846;96.0;4380.0;;;;No BRCA mut;Yes;;HRD;;No;Hypercholesterolemia, Osteoporosis;No;breastcancer;;;
patient4;;65;30,48668503;high grade serous;;;IVA;PDS;;;;;;;over 5cm;;6.0;3.0;4;no;No;ND;;;;;;Partial Response to NACT;Yes;Progressive Disease;;Yes;Alive;death due to cancer;170;;835.0;-23.0;688.0;;BRCA2 in tumor, BRCA2 in blood;Yes;;HRD;Insuff material;Yes;Hypercholesterolemia, Osteoporosis;no;;;;
patient5;Ovaries removed before NACT;81;22,59515571;high grade serous;;;IIIC;PDS;;;No;;No;;over 5cm;over 5cm;4.0;3.0;;no;ND;ND;;Yes;;;;Stable Disease after NACT;;Partial Response;;No;Alive;;188;715.0;567.0;;921.0;;No BRCA mut;No;HRP;HRD;HRD negative;Yes;Meniereâ€™s disease;no;Breast cancer;;;
patient6;;80;24,80614174;high grade serous;;;IVA;PDS;0;;;No;;;Less than 2cm;;9.0;3.0;;no;No;Yes;DOVACC;Yes;;2;;Partial Response to NACT;;Partial Response;;Yes;Dead;death due to cancer;816;880.0;135.0;0.0;687.0;;No BRCA mut;No;HRD;;;Yes;Hypertension, Hypothyreosis;No;;;;
patient7;lung emboly, dg lscopy cancelled, Dg form ascites and pleural fluid,   ;41;23,23345618;high grade serous;;;IIIC;PDS;0;1 to 10mm;No;No;;;over 5cm;;3.0;1.0;;bevacizumab;No;ND;FIRST;;No iOme samples;;;;Yes;Partial Response;;Yes;Alive;death due to cancer;660;769.0;7.0;;;;;Yes;HRP;;HRD positive;Yes;Hypercholesterolemia, Hypertension, Hypothyreosis;Yes;;;;
patient8;;73;19,48696145;high grade serous;;;IIIC;NACT;0;;;Yes;;;;;6.0;;4;no;No;ND;;Yes;3;;;Stable Disease after NACT;;Partial Response;PARP maintenance after prim therapy;No;Dead;;1004;473.0;4178.0;;;;;;HRP;HRD;;Yes;Astma,  takotsubu sdr, Hypercholesterolemia;No;breastcancer;;;
patient9;large 12cm liver met in 1st relapse, marker normal;65;27,26276928;high grade serous;;HGSC/IGSC (intermediate grade serous carcinoma);IVB;PDS;;;No;;No;;over 5cm;;6.0;4.0;;;No;ND;;No;No iOme samples;;;Stable Disease after NACT;Yes;Complete Response;Progression;ND;Dead;death due to cancer;1431;459.0;25.0;;1512.0;;;;HRP;HRP;;Yes;PSC = prim. sklerosoiva kolangiitti;Yes;;;;
patient10;;59;26,74553636;high grade serous;;;IIIC;PDS;0;;;No;;;over 5cm;Over 5cm;6.0;;3;;ND;No;;Yes;2;1;;;;ND;Hormonal treatment;No;Dead;;916;68.0;91.0;;680.0;;BRCA1 in blood, BRCA1 in tumor;;HRP;HRD;;Yes;Hypertension, Diabetes type2, Flimmer, Hypercholesterolemia;No;;;;unsure dg, palliative
patient11;Dg from biopsy, recruited after NACT;62;31,4453125;high grade serous;yes;;IIB;NACT;;more than 10mm;;;;;over 5cm;No;10.0;3.0;;Bevacizumab;No;ND;;Yes;;;Yes;Partial Response to NACT;;Complete Response;Progression;Yes;Alive;;1161;1845.0;556.0;;1287.0;;No BRCA mut;No;HRD;;;Yes;Flimmer, Hypercholesterolemia, Reflux ;No;;;;
patient12;;63;22,77318641;high grade serous;;;IIIA1;PDS;;;No;;;Yes;Over 5cm;2 to 5cm;5.0;3.0;5;no;No;ND;;;2;;;;Yes;Partial Response;;Yes;Dead;;120;1427.0;0.0;;;;No BRCA mut;No;HRP;;;Yes;Hypercholesterolemia;No;;1995;;
patient13;;74;27,6816609;high grade serous;;;IVB;PDS;0;;;;;;over 5cm;over 5cm;6.0;;;no;No;Yes;;;;;;Stable Disease after NACT;;Complete Response;;Yes;Alive;;1621;747.0;3087.0;;;;No BRCA mut;No;;HRD;;Yes;Hypothyreosis;No;;;;
patient14;;73;30,48668503;high grade serous;;;IVB;NACT;0;;No;No;No;;over 5cm;2 to 5cm;7.0;;3;bevacizumab;No;No;DUO-O;;2;2;;Progressive disease after NACT;Yes;Complete Response;Regular follow up visits ended;No;Alive;;1274;188.0;64.0;;137.0;;;No;;HRD;;No;Astma;No;;2008;;
patient15;Dg from radiologic biopsy. No primary fresh samples.;73;28,5218254;high grade serous;;;IIIC;PDS;1 to 10mm;0;No;No;No;;over 5cm;;9.0;6.0;3;no;No;ND;;;2;2;Yes;Stable Disease after NACT;;Partial Response;;Yes;Alive;death due to cancer;1406;35.0;79.0;;804.0;;No BRCA mut;No;;HRD;;Yes;No;No;;;;
patient16;colon ca 4 years after ovca, died due to colon ca;78;24,6097337;high grade serous;yes;HGSC;IIIC;PDS;0;1 to 10mm;No;;;;over 5cm;;6.0;3.0;;Bevacizumab;No;No;;;2;;;;No;Complete Response;Regular follow up visits ended;Yes;Dead;;439;725.0;203.0;-22.0;427.0;;No BRCA mut;No;HRP;HRP;;Yes;;No;;2005;;
patient17;bifasic, both HGSC and endometroid in interval sample. No clear prog, died due to other disease;67;45,28172925;high grade serous;;HGSC;IIIC;PDS;0;0;No;;;Yes;Over 5cm;;;;;ND;Yes;ND;PRIMA;;;;;;;ND;;Yes;Dead;;1576;817.0;568.0;;450.0;;No BRCA mut;No;;;;Yes;No;Yes;;;;
patient18;Ovaries removed before NACT;77;22,83737024;high grade serous;;;IVB;PDS;;;;;No;;Over 5cm;;;;;;ND;No;;Yes;;2;;;Yes;Complete Response;Regular follow up visits ended;Yes;Dead;;2623;4506.0;313.0;;655.0;;No BRCA mut;;HRD;HRP;HRD positive;No;MCC;No;;;;
patient19;;59;24,05876951;high grade serous;;;IIIC;NACT;;;;;;Yes;Less than 2cm;;9.0;; 9;No;Yes;ND;;Yes;;;;;;Complete Response;Bev maintenance after primary therapy;Yes;Dead;;333;3282.0;2190.0;;621.0;;No BRCA mut;No;HRD;HRD;;No;Hypertension;No;;;;
patient20;DG from radiologic biopsy +asc ;67;18,359375;high grade serous;;;IIIC;NACT;1 to 10mm;0;;;;Yes;;;6.0;;;;No;ND;PAOLA;;;;;Partial Response to NACT;;Stable Disease;;Yes;Dead;;340;575.0;70.0;0.0;292.0;Yes;BRCA2 in tumor;No;HRD;HRD;;Yes;Glaucoma, Hypertension;no;;;;no prim chemo
